Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B DREYER

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Human Gene Therapy|July 31, 1999
bcl-2 gene therapy exacerbates excitotoxicityP D Simon, C K Vorwerk, S S Mansukani, et al.
AIDS Research and Human Retroviruses|December 1, 1992
Effect of a human immunodeficiency virus protease inhibitor on human monocyte functionP J Bugelski, J M Kaplan, T K Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
An astrocytic binding site for neuronal Thy-1 and its effect on neurite outgrowthE B Dreyer, D Leifer, J E Heng, et al.
Investigative Ophthalmology & Visual Science|September 28, 2000
Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell deathC K Vorwerk, R Naskar, F Schuettauf, et al.
Biochemistry|January 26, 1993
A symmetric inhibitor binds HIV-1 protease asymmetricallyG B Dreyer, J C Boehm, B Chenera, et al.
Investigative Ophthalmology & Visual Science|October 23, 1997
The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicityC K Vorwerk, B T Hyman, J W Miller, et al.
Antiviral Research|August 1, 1993
Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infectionD M Lambert, H Bartus, A V Fernandez, et al.
Antiviral Research|March 1, 1996
Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in miceP l Black, M A Ussery, S Barney, et al.
Biochemistry|September 6, 1991
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 proteaseS K Grant, I C Deckman, M D Minnich, et al.
Annals of Surgical Oncology|November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerStephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Human Gene Therapy|July 31, 1999
bcl-2 gene therapy exacerbates excitotoxicityP D Simon, C K Vorwerk, S S Mansukani, et al.
AIDS Research and Human Retroviruses|December 1, 1992
Effect of a human immunodeficiency virus protease inhibitor on human monocyte functionP J Bugelski, J M Kaplan, T K Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
An astrocytic binding site for neuronal Thy-1 and its effect on neurite outgrowthE B Dreyer, D Leifer, J E Heng, et al.
Investigative Ophthalmology & Visual Science|September 28, 2000
Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell deathC K Vorwerk, R Naskar, F Schuettauf, et al.
Biochemistry|January 26, 1993
A symmetric inhibitor binds HIV-1 protease asymmetricallyG B Dreyer, J C Boehm, B Chenera, et al.
Investigative Ophthalmology & Visual Science|October 23, 1997
The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicityC K Vorwerk, B T Hyman, J W Miller, et al.
Antiviral Research|August 1, 1993
Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infectionD M Lambert, H Bartus, A V Fernandez, et al.
Antiviral Research|March 1, 1996
Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in miceP l Black, M A Ussery, S Barney, et al.
Biochemistry|September 6, 1991
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 proteaseS K Grant, I C Deckman, M D Minnich, et al.
Annals of Surgical Oncology|November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerStephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
Pageof 10